CBD Gummies for Arthritis: What Real-World Experience and Available Evidence Actually Show
CBD gummies arthritis use is growing among patients seeking alternative pain relief. Real-world experience shows mixed results, with limited clinical evidence available. Understanding these insights helps clinicians guide arthritis patients effectively.
Over 70% Of Studies Back Medical Cannabis In Cancer Treatment: A Sweeping Meta-Analysis
A medical cannabis cancer treatment meta-analysis found that over 70% of studies demonstrate clinical benefit. This meta-analysis supports cannabis use in oncology for symptom management. The findings highlight cannabis's role in cancer supportive care.
Evaluating FABP5 as a Therapeutic Target for Pain Management.
FABP5 pain management is emerging as a promising non-opioid approach to analgesia. Pharmacological inhibition of FABP5 shows analgesic effects in preclinical pain models. This target modulates cannabinoid receptor signaling, offering new insights into…
Chinese Researchers Develop Cannabis-Based Molecule with Strong Pain Relief, Fewer Side Effects
Synthetic cannabinoid development is a promising area for pain relief with fewer side effects. Chinese researchers have created a novel cannabis-based molecule showing strong analgesic potential. This development could expand treatment options for…
Medical Cannabis Counseling for Older Adults: What Physicians Are Telling Patients
Medical cannabis counseling is increasingly important for older adults as many seek advice on pain, sleep, and anxiety. Physicians often feel underprepared to provide detailed, age-specific guidance. This study highlights the growing need for better…
Cannabis Boom: Innovations Rise, Health Gains Lag Behind
The clinical cannabis evidence gap highlights the disconnect between rapid product innovations and limited health gains. Despite industry growth, clinical trials supporting therapeutic efficacy remain scarce. Clinicians must navigate this gap carefully…
Dr. Oz’s CBD Gummies: Separating Fact From Hype On Pain Relief – Fathom Journal
Cannabinoid efficacy pain relief remains a complex topic as research evolves. This article examines the evidence behind CBD gummies marketed for pain relief. Understanding the distinction between scientific data and marketing claims is essential for…
Dallas Hemp Shops React to Texas Hemp Regulations Impact
Texas hemp regulations impact patient access to delta-8 THC products used for symptom management. Regulatory uncertainty creates challenges for patients relying on these cannabinoids. Dallas hemp shops react to the stalled Texas THC ban and its effects…
Virginia’s Hemp Crackdown and the Return of Prohibition | Cato at Liberty Blog
Virginia hemp enforcement changes directly affect patient access to hemp-derived CBD products. These changes create clinical uncertainty about product availability and legal status. Healthcare providers should monitor these developments closely.
Daily Temporal Associations Between Psychoactive Substance Use and MS Symptoms
This study investigates psychoactive substance use multiple sclerosis patients experience daily. Using ecological momentary assessment, it tracks symptom fluctuations and substance use patterns. Findings reveal complex, symptom-dependent relationships…